$2,042 Profit
VLALong Stock
Entry comments: SLD POSITION
Exit comments: SLD HALF POSITION; €/$: 1,38 Remaining catalysts: 1/ Novartis decision clinical trial in pseudomonas 2/Potential approval in Japan w/ Kaketsuken (H5N1) 3/ Update GSK flue vaccine
| Date | Price | |
|---|---|---|
| Entry | 1/12/2014 | 4.47 |
| Exit | 2/23/2014 | 7.43 |
- Total Views109
- Position Size500
- Percentage66.22%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
